Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort.

The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance. J Immunobiol (2016) 0.75

Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated? Curr Hepatol Rep (2017) 0.75

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Transl Hepatol (2017) 0.75

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57

Hepatocellular carcinoma. N Engl J Med (2011) 19.40

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 16.93

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84

Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (2010) 4.83

Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 4.73

Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Ann Intern Med (2014) 4.34

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis (2011) 3.74

Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol (2013) 3.12

Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol (2007) 2.73

Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut (2011) 1.98

Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol (2005) 1.77

Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol (2008) 1.71

Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med (2012) 1.57

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52

Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer (2002) 1.48

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer (2010) 1.34

Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int (2007) 1.16

Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci (2009) 1.09

Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol (2007) 1.07

Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver Int (2008) 1.02

Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol (2014) 1.01

Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology (2001) 1.00

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. J Hepatol (2014) 0.99

Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol (2015) 0.96

Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology (1998) 0.92

Screening process failures for hepatocellular carcinoma. J Natl Compr Canc Netw (2014) 0.90

Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther (2016) 0.85

Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Ann Hepatol (2013) 0.77